Edition:
India

Syngene International Ltd (SYNN.NS)

SYNN.NS on National Stock Exchange of India

615.80INR
19 Jan 2018
Change (% chg)

Rs24.20 (+4.09%)
Prev Close
Rs591.60
Open
Rs592.75
Day's High
Rs620.00
Day's Low
Rs590.50
Volume
188,308
Avg. Vol
150,788
52-wk High
Rs620.00
52-wk Low
Rs430.10

Chart for

About

Syngene International Limited is a contract research company. The Company is engaged in providing contract research and manufacturing services in early-stage drug discovery and development to pharmaceutical and biotechnology companies. Its services include discovery chemistry and biology services, toxicology, pharmaceutical... (more)

Overall

Beta: --
Market Cap(Mil.): Rs98,010.00
Shares Outstanding(Mil.): 200.00
Dividend: 1.00
Yield (%): 0.20

Financials

BRIEF-Syngene International ‍expands collaboration with Bristol-Myers Squibb​

* Nnext phase of partnership will see addition of facility to support future Bristol-Myers Squibb research and development operations​ Source text: http://bit.ly/2iT2tvz Further company coverage:

14 Nov 2017

BRIEF-India's Syngene International Sept-qtr profit rises 3 pct

* Sept quarter net profit 769 million rupees versus profit of 747 million rupees last year

25 Oct 2017

BRIEF-Syngene International confident that impact of fire incident of last yr to taper off in coming qtrs

* Says confident that the impact of the fire incident of last year will taper off in the coming quarters

27 Jul 2017

BRIEF-India's Syngene International June-qtr profit rises about 4 pct

* June quarter profit 620 million rupees versus 598 million rupees last year

27 Jul 2017

Earnings vs. Estimates